TNFSF10 and neoplasm: Due to its cancer cell specific death-inducing activity, TRAIL has been regarded as a potential protector or inhibitor of tumor generation and progression [2, 3]; however, lots of tumor cell lines and primary cancer cells are resistant to TRAIL-induced apoptosis [4–6].